Navigation Links
The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines

s have to be HIV-negative when they sign up.

In the fourth and last phase -- if the results of earlier phases are found to be satisfactory -- marketing of the vaccine is done and post-marketing surveillance carried out. Experts say it takes years for a successful vaccine to be developed.

The International AIDS Vaccine Initiative (IAVI), which coordinates the global search for a vaccine, says India is important because of its advanced biomedical research facilities and strong pharmaceutical industry which has developed cheap and effective AIDS drugs that are exported across the globe.
'"/>




Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
(Date:12/14/2009)... Americold Realty Trust ("Americold") announced today that it has ... U.S. Securities and Exchange Commission (the "SEC") relating to ... The number of shares to be offered and the ... determined. The common shares to be sold in this ... ,, The joint book-running managers of the offering will ...
(Date:12/14/2009)... -- Aflac Incorporated announced today that it has ... notes with a coupon of 6.9%. The notes ... to yield 6.984%. The company anticipates using the ... general corporate purposes. ,, Commenting on the pricing ... Chief Financial Officer Kriss Cloninger III commented: "This ...
(Date:12/14/2009)... -- Tough Enough To Wear Pink(TM) (TETWP), the ... its fifth anniversary at the signature Tough Enough ... Finals Rodeo (Wrangler NFR) in Las Vegas. While ... cowboys, the support of the western industry and ... sported pink shirts, hats, bracelets and more. ...
(Date:12/14/2009)... 13 years under government controlled health care, before moving to the ... engagements and in his new book, Health Reform: The End of ... a system and its threat to real health care! , ... ... a diagnostic radiologist from Minnesota, warns Americans not to sell out ...
(Date:12/14/2009)... Dec. 14 Skilled nursing facilities (SNFs) in ... in order to deal with a 92 percent increase ... from $6.25 to $12.01 per bed per day, scheduled ... average facility will pay an additional $17,520 to the ... total tax of $438,365 yearly. ,, Nearly 96 percent ...
Breaking Medicine News(10 mins):Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3
... ArlenGroup, the leading provider,of employee benefit consulting and ... law firms, announces the expansion of its West ... Rees LLP has entered the,Consortium beginning January 1, ... LLP, and Wilson Sonsini Goodrich & Rosati PC ...
... from the Center for Bioinformatics at Peking University ... atlas underlying drug addiction and identified five molecular ... This novel paper appears in PLoS Computational Biology ... a serious worldwide problem with strong genetic and ...
... workers or those with narcolepsy, scientists say , FRIDAY, Jan. ... orexin-A may be key to undoing the negative mental effects ... Orexin-A is a peptide (a kind of protein) made in ... the Wake Forest University School of Medicine in Winston-Salem, N.C. ...
... key articles of interest to caregivers and those who suffer ... of leukemia, and how different societies have looked at the ... describe new research based on identifying the many variations ... sub-types more precisely , show ...
... Highest Honor for Organizational Performance Excellence, ANN ... (MQC) announces Oakwood Healthcare, Inc. as a 2007 ... Award is the highest honor for,organizational performance excellence ... review by a team of examiners who perform ...
... The Michael J. Fox,Foundation has committed up to ... therapeutic to treat Parkinson,s disease by reducing expression,of ... by Matt Farrer,PhD, of Mayo Clinic Jacksonville (Florida) ... and Clinical Center will work,to optimize a small ...
Other Medicine News:Health News:Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium 2Health News:Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium 3Health News:Protein Nasal Spray Revives Sleep-Deprived Monkeys 2Health News:Michigan Quality Council (MQC) Names Oakwood Healthcare Inc. 2007 State Quality Award Recipient 2Health News:Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease 2Health News:Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease 3
(Date:12/14/2009)... Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ) today ... Allowance from the United States Patent and Trademark ... no. 11/060,641, which covers the composition and use ... the lead Transcept product candidate. Once issued, ... 2025. ,, "This is the second USPTO Notice ...
(Date:12/14/2009)... -- In response to an FDA notice ... the Agency recommended that healthcare facilities discontinue use ... system, hospitals throughout the U.S. are faced with ... product. According to the FDA, STERIS made changes ... affect the safety or the effectiveness of the ...
(Date:12/14/2009)... Dec. 14 The board of directors of ... today declared a dividend for the first quarter of ... ,, The dividend is payable March 10, ... business on ,, February 12, 2010. ,, Lilly, ... of pharmaceutical products by applying the latest research from ...
Breaking Medicine Technology:Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Pharma and Biotech Leaders to Converge in Shanghai 14765 1Pharma and Biotech Leaders to Converge in Shanghai 14765 2CEL SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 14763 1CEL SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 14763 2CEL SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 14763 3AMD LASERS Names Dr James Jesse as Medical Director 6091 1AMD LASERS Names Dr James Jesse as Medical Director 6091 2
... Assess the Safety and Efficacy of ORMD 0801, Oral Insulin Capsule, ... ... (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer,of oral delivery systems, announced today ... capsule, on Type 1 diabetics at the,Hadassah University Medical Center in Jerusalem, ...
... SAN MATEO, Calif., Sept. 24 Anthera ... the U.S. Food and Drug,Administration (FDA) on ... in acute,coronary syndrome (ACS) under the FDA,s ... the company received Scientific Advice from,the European ...
Other Medicine Technology:Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics 2Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 2Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 3
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Micro Vitreoretinal Cannula; Angled; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 65°, 1mm from Tip....
...
...
Medicine Products: